0001104659-24-081516.txt : 20240722 0001104659-24-081516.hdr.sgml : 20240722 20240722163011 ACCESSION NUMBER: 0001104659-24-081516 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240719 FILED AS OF DATE: 20240722 DATE AS OF CHANGE: 20240722 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saggar Rajeev CENTRAL INDEX KEY: 0001935638 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39724 FILM NUMBER: 241131852 MAIL ADDRESS: STREET 1: 419 DAVIS DRIVE STREET 2: SUITE 100 CITY: MORRISVILLE STATE: NC ZIP: 27560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Liquidia Corp CENTRAL INDEX KEY: 0001819576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851710962 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 419 DAVIS DRIVE, SUITE 100 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919.328.4400 MAIL ADDRESS: STREET 1: 419 DAVIS DRIVE, SUITE 100 CITY: MORRISVILLE STATE: NC ZIP: 27560 4 1 tm2419910-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-07-19 0 0001819576 Liquidia Corp LQDA 0001935638 Saggar Rajeev 419 DAVIS DRIVE SUITE 100 MORRISVILLE NC 27560 0 1 0 0 Chief Medical Officer 1 Common Stock 2024-07-19 4 S 0 1873 11.13 D 208329 D Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on July 18, 2022. Includes (i) 23,458 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 52,082 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 56,492 RSUs granted to the Reporting Person on January 11, 2024, none of which have vested as of the date of this Form 4 and (iv) 3,604 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. /s/ Dr. Rajeev Saggar 2024-07-22